Eric Karl Neumann, Ph.D.

CURRENT EMPLOYMENT

Clinical Semantics Group Consulting

• Clinical and Healthcare consultation for Industry, Government, and Academia
• Next generation Cyberinfrastructure for Information and Knowledge Management
• Development and Application of Enabling Technologies for Drug R&D (Maglev)
• Semantic Strategies for Translational Research
• Research and Development of new enterprise-wide knowledge mining approaches (IKP)
• Evaluation of Applications and Semantic Web technologies for all parts of Pharmaceutical R&D

CURRENT Affiliations

MIT Fellow, Science Commons

• In support of the Neurocommons Projects
• Speaker for SC Activities
• Liaison for Collaboration Partnerships
• Semantic Technology Advisor

W3C Consortium Chair Role

• Manage and grow W3C's Healthcare and Life Science Interest Group (HCLSIG)
• Organized two international “Face-to-Face” meetings and two workshops
• Coordinator for Task Force on Drug Safety and Efficacy within HCLSIG
• Supported the creation of life sciences best practices documents and demonstrations
• Editor for Journal on Web Semantics Special Issue for Life Sciences
• Presented as speaker and panelist at several conferences

MOST RECENT EMPLOYMENT

Senior Director, Product Strategy, Teranode

• Dec 2005 - March 2007
• Define and execute Teranode’s Semantic Web Strategy for pharmaceuticals
• Define the enterprise collaborative framework for drug R&D
• Assist in the development of a demonstration
• Define the Preclinical and Clinical Product line
• Chair W3C’s Healthcare and Life Science interest group

Clinical Semantics Group Consulting,

• June 2005 - Present
• Clinical and Healthcare consultation for Industry, Government, and Academia
• Semantic Strategizing
• Applications and Semantic Web technologies

Global Head Knowledge Management, Sanofi-Aventis Pharmaceuticals

• January 2004 – June 2005
• Based in Bridgewater, NJ, responsibility over Paris and Frankfurt
• Jan 2005 – Reporting to Information Management within Scientific and Medical Affairs (R&D).

Responsibilities

• Global KM Head for all reporting KM sites worldwide
• US KM Site Head
• Ensure effective collection and utilization of knowledge for all of R&D, including Discovery, Lead Development, Preclinical, Clinical and Regulatory Affairs
• Helped redefine KM during Sanofi and Aventis merger
• Coordination with Information Management and Information Services
• Negotiated and managed contract research with Interactive Systems to build Knowledge System
• Support Knowledge networking practices and methodologies for Scientific & Medical Affairs
• Knowledge Technology Initiatives for Knowledge Management
• Development and deployment of Lessons Learned methodologies
• Development and integration of Semantic Technologies for Discovery Scientists
• Development of metrics for impact assessment
• Creation and embedding of Knowledge Maps in Clinical and Regulatory Affairs

PREVIOUS EMPLOYMENT AND POSITIONS

• Vice President of Bioinformatics, Beyond Genomics, Waltham, MA
• Vice President of Life Sciences Informatics, 3rd Millennium, Inc. Cambridge, MA
• Life Sciences Informatics Consultant, 1999.
• 1997-1999 Director of Research, NetGenics, Inc. Cleveland, OH.
• Senior Scientist for research and development in the Intelligent Systems and Education Technologies Departments, BBN System and Technologies, Bolt, Beranek, and Newman, Inc., 1990-1997.

EDUCATION

• 2003 Harvard Business School, Executive Course on “Leveraging Knowledge”, Prusak, Davenport, Leonard.
• 1987-1990 Postdoctoral fellow at Brandeis University, advisor Dr. Jeffrey Hall. Molecular analysis of mutations affecting courtship songs of Drosophila.
• 1989 Ph.D. Case Western Reserve University (Pharmacology, Neurobiology, Developmental Genetics), advisor Dr. Anthony Mahowald
• 1977-81 B.S. Massachusetts Institute of Technology, B.S. in Life Sciences.

PREVIOUS ACCOMPLISHMENTS

Sanofi-Aventis

• Successfully defined the new Knowledge Management paradigm for Aventis
• Supported Chemical Biology communities of practice over 3 sites
• Supported the research and demonstration of a Knowledge System for chemistry
• Created a forum for Semantic Technologies work at Sanofi-Aventis
• Promoted the initiation of the Semantic Web for Life Sciences
• Helped in the establishment of Information Management withing the forming Sanofi-Aventis organization

Genstruct

• Co-founder and SAB member
• Collaboration within Beyond Genomics
• Helped define business model and technology platform
• Advanced their proprietary technology: “Knowledge Assembly”
• Introduced Genstruct to Pfizer, current major customer

Beyond Genomics

• Successfully presented Beyond Genomics’ scientific vision to prospective companies which lead to 3 pharmaceutical deals (including GSK and Novartis) with Beyond Genomics
• Helped negotiate contracts with major pharmaceutical companies, including supporting their biomarker data interface needs
• Built and managed successful groups for quantitative (biostatistics) and structural bioinformatics while vice president of Bioinformatics
• Knowledge Management System that combines experimental data with structured data and mined literature
• Defined the Value Proposition for a Drug Discovery model based on Data-Analysis-Driven Systems Biology
• Developed an Econometric Pharmaceutical model for Systems Biology
• Designed and oversaw novel Statistical Models and Next-Generation computational mining methodologies
• Proteomic Mining tools that utilize transcriptomic information
• Proposed, evaluated, negotiated, and managed the collaborative creation with Sun Microsystems of a large-scale computational cluster system for data analysis
• Oversaw development of an advanced LIMS platform and statistical pipeline for Systems Biology data
• Data interchange pipeline model based on dynamic XML forms

3rd Millennium

• Responsible for a winning competitive IT proposal to GeneProt, a major Proteomics company
• Responsible for a winning competitive proposal to Biogen
• Developed new models for use in proteomics, gene profiling, and pathway informatics
• Developed series of ontologies that link major aspects of life sciences together: Chem-Bio Bridge
• Author and awarded PI of a $1.8 million ATP-NIST for Pathway Informatics
• Founder and organizer of the international BioPathways Consortium

NetGenics, Inc. (acquired by LION)

• Research and Development of an automated XML interoperable wrapper (Plug-In) published-service solution
• Integrated expression technology and visualizations
• Negotiated deals with several partnering IT and scientific vendors
• Research into a common semantic (ontology) data model

Bolt, Beranek, and Newman, Inc.

• Developed grant applications and funded for 6 years by NSF for advanced Genetics Modeling
• Designed and co- implemented a large-scale object model for molecular and population genetics
• Explored new forms of data visualization and auralization
• Developed several mathematical dynamic models for Biology (disease, heart, evolution, biochemical regulation)

CURRENT CONSORTIUM AND BUSINESS RELATIONS

• Lead for the public BioDash initiative (www.w3.org/2005/04/swls/BioDash/demo/)
• Organizer for the W3C “Semantic Web for Life Sciences” interest group
• Member of Organizing Committee for Elsevier-Reed PHARMADISCOVERY
• Drug Discovery Today: BioSilico Editorial Board
• Bio-Ontologies co-founded with David Benton, GSK
• BioPathways Consortium founder and organizer
• Chair for the Pathways/Systems Biology sessions 2001-2004 at the Pacific Symposium for Biocomputing
• Sun’s Life Sciences Initiative (I3C)
• Sun advisory member (IAC)
• Oracle advisory member (CAB)
• Advisor for Cambridge Healthtech (CHI) meetings; Beyond Genome organizer

Management Experience

• Sanofi-Aventis
  • Global Head Knowledge Management
  • Member of the Information Management group
  • Member of Aventis Discovery Research “Druggable Target” group
  • Sponsor for the Semantic Technology working group
• Beyond Genomics
  • Head of Strategic Informatics Knowledge Research
  • Managing Pharmaceutical-specific Knowledge Research Project
  • Senior Management for IT, Bioinformatics, and Advanced Informatics Departments
  • Lead Team to design HTS of cell lines using Systems Biology platform
• 3rd Millennium
  • Project coordinator and manager for several high-profile client engagements at 3rd Millennium.
  • Science & Technology Strategist
  • VP of Life Science Informatics, business and technology strategic development, bioinformatic core-group establishment
• NetGenics
  • Director of the Research Department directly involved in the management and coordination of a nine-member team, that is working on several advanced life science technologies projects.
  • Head of a strategic Roadmap Group.
  • Manager of the Domain Analysis Group
  • Central coordinator of information between Marketing, Sales, Design, and Software Development, 1997-1999.

RESEARCH EXPERIENCE

• Modeling and analyzing complex data to study relations between Cardio-Vascular Diseases
• Research on next Generation Genomics-Pathway Knowledge-Base funded by NIST
• Research of Gene Expression Technology (visualization and analysis)
• Research on an adaptive Plug-in Service Adapter
• Distributed technologies research, with particular focus on cross-domain informatics integration and knowledge-base modeling, Research Dept, NetGenics
• Modeling of Biochemical Pathway and Interaction data using Multiple Knowledge Representations
• Modeling complex biological systems across multiple levels of representation, Systems and Technologies, BBN.
• Bio-acoustic and behavior classification of mutant Drosophila courtship using Artificial Neural Networks, Dr. Jeffrey Hall, Brandeis University.
• Molecular and genetic analysis of Drosophila embryonic neurogenesis using differential cDNA screening, Anthony P. Mahowald, Ph.D. advisor, Dept. of Developmental Genetics and Anatomy, Case Western Reserve University.
• Molecular Recombinants of Murine Leukemia Viruses Which Alter Tissue-Specific Tropisms, Dr. Nancy H. Hopkins, Ph.D., advisor, M.I.T.

COMPUTER SCIENCE AND BIOINFORMATICS EXPERIENCE

• Semantic Web Drug Discovery protocol that wraps pre-existing databases and enables global annotations
• Life Science Semantic Web prototype BioDash project at W3C (www.w3.org/2005/04/swls/BioDash/demo/)
• Researched the use of semantic languages (RDF and OWL) for life sciences and pharmaceutics
• Designer of Advanced Proteomic Data Models
• Architect of several Life Science Ontologies (familiarity with Protege)
• Extensive interfacing/programming skills in RDF-OWL, XML/XSL, Ruby-Rails, Java, PERL, C++, SmallTalk, and LISP
• Extensive knowledge and experience in bioinformatic algorithms and data-mining
• Broad experience in advanced human-factors GUI development
• Experience in modeling of complex biological phenomena
• Major involvement in CORBA IDL standards specifications and implementations
• In-depth knowledge of metadata handling and database representations
• Research and design of Knowledge-base models and their extended uses
• Fluent in the use of Mathematica and MatLab for analytical computation

ACTIVITIES AND PROJECTS

Dr. Eric Neumann has been actively involved in advancing distributed technologies that support and inter-link bioinformatics, genomic, genetic, and protein information, as well as the tools that can be applied to each. He is also active in supporting and providing guidance for Open Standards within bioinformatics and the rest of the Life Sciences, currently through W3C Domain specific activities. Some specific areas he is been directly involved in over the last 4 years include:

• ToxDash: W3C prototype for advancing drug safety drug development
• BioDash: The use of W3C’s OWL-RDF language for machine-readable annotations of biological findings and hypotheses
• Participation with BioPAX pathway standard
• Pathway reconstruction using statistical modeling and information-theoretic approaches
• Creator and designer of an advanced Expression Informatics technology that could be integrated around multiple expression formats.
• Integrated Metabolic and Signaling Pathway modeling from multiple pathway sources
• Zero-Information solutions for bioinformatic encryption
• Designed and developed multi-variable data visualization tool with filtering capability in Java
• Active contributor to the LSR Biosequence Analysis specification at OMG
• Media object annotations and distributed links in CORBA
• Design of an extensible ontological management system
• Development of an ontology browser and editor
• Design and development of a Relationship Service that links distributed objects together so that they can be searched via associations
• Development of an interactive 3D protein structure viewer in Java
• Design and Development of Genomic and Genetic Map models and viewers, specifically with access the ACeDB models
• Novel algorithms for use in Comparative Genomics
• Chairperson for LSR Roadmap, in which my role is to plan where distributed object technologies need to proceed in the Life Sciences

PREVIOUS PROJECTS

As Director of Research at NetGenics, Dr. Neumann initiated and guided several projects involving intelligent data and tool integration, including the Plug-in Service Adapter, 3D macromolecular viewer, gene expression analysis system, an integrative 2D-gel proteomic navigator, integration of metabolic pathways (KEGG), a genomic database viewer, and a document management system. Some have become key features for the NetGenics’ Synergy product. During Dr. Neumann’s BBN employment, he developed software for use in mammogram clinical analysis and medical report writing. He designed and implemented a dynamic, interactive, computer-based biological model of the heart (Cardio). He has also designed computer-based tools for the interactive exploration of chemical dynamics and Turing structures. Dr. Neumann is the originator and co-principal investigator of "Multi-level Science: from DNA to Populations", which continues to investigate the use of a genetics-modeling environment (GenScope) for use in education. He also was a co-principal investigator of the NSF-funded "Turning Information into Knowledge" Project, which is investigating the effectiveness of multilevel science technologies, or Hypermodels, by teachers and students as part of their curriculum. Dr. Neumann has been actively involved in research of neurobiology and the genetic basis of behavior for several years. He has extensive experience in the research, development, and analysis of various computer-based neural network models for their use in signal processing. He has also developed a novel method for the study of animal behavior and communication. While at Brandeis, Dr. Neumann analyzed and characterized the cacophony song mutant, and initially identified the corresponding Drosophila calcium channel gene, CCA1_DROME, involved in visual functions and behavior phenotypes.

COMMITTEES, MAJOR PRESENTATIONS, AND WORKSHOPS

• Chair, Conference on Semantics in Health and Life Sciences (CSHALS), March 5-7, 2008
• Semantic Web Panel at Drug Discovery Technologies, August 6, 2007
• Tutorial, Clinical Data Management DIA, Orlando, March 18, 2007 (slides)
• NIH Panel on Knowledge Environments, Dec 2006
• Semantic Web Panel at AMIA, November 11, 2006
• Neuroscience Informatics Panel, Oct 2006
• Organizer for W3C HCLS workshop at ISWC Nov 6, 2006
• Semantic Web Panel at Drug Discovery Technologies, August 9, 2006
• BioIT-World Panel on Semantic Web, April 2006
• Future of Informatics at Presentation at Infotech March 2006, London
• Informatics Workshop at Molecular Medicine, February 2006
• Organized first formal face-to-face meeting for Semantic Web in Healthcare and Life Sciences, Jan 25, 2006
• Presentation at RCRIM Technical Committee, HL7, Jan 9, 2006
• Paper Presentation on Applying BioDash to Drug Development, PSB06
• Semantic Web Presentation at Drug Discovery Technologies, August 12, 2005
• Presentation at Bio-ITWorld, August 9, 2006
• Organizer and Presenter for first W3C workshop on Semantic Web for Life Sciences, Oct 27-28, 2004
• Session Organizer for SBS 2004, “Pathway Analysis in Screening”
• Session Organizer and chair for Computational and Symbolic Systems Biology PSB04.
• Organizer for ACS Symposium “Rendering Biological Knowledge from Proteomics and Genomics”, Nov 2003.
• Invited Speaker to Bioinformatics Gordon Conference 2003, Oxford, UK.
• Presentation and Knowledge Management Workshop at Drug Discovery technology, 2003.
• BIO 2003 Panel on Systems Biology.
• Invited Speaker to NIDA/NIH meeting on Systems Biology and Neurobiology, March 2003.
• Session co-chair for PSB 2003 Meeting in Hawaii.
• I3C “Informatics Standards and Solutions” Presentations at ISMB 2001 and O’Reilly Bioinformatics 2002.
• Invitational Open-Platform summit meeting sponsored by BIO, Oracle, and Sun.
• Organizer for the sponsored BioPathways Consortium ISMB 2001 Meeting in Copenhagen.
• Session Co-chair along with Peter Karp for “Pathways, Interactions, and Genomics” at PSB01 and PSB02, Hawaii.
• Organizer for the sponsored BioPathways Consortium PSB 2001 Meeting in Hawaii.
• Presentation on “Intelligent Information Integration” at Research Informatics2001, Phila, PA.
• Founder and Organizer for the BioPathways Consortium, San Diego 2000.
• Bio-Ontologies 2000 Meeting co-organizer, August 24, 2000, San Diego, CA.
• Workshop organizer at CHI In Silico Conference, San Francisco, June 2000.
• Chair of Bioinformatics work group, Massachusetts Biotech Council
• Bio-Ontologies 99 Meeting organizer, August 5, 1999, Heidelberg, Germany.
• Co-founding member (along with SmithKline) of the Bio-Ontologies Consortium
• Founding co-chair of the Life Science Task Force at the Object Management Group, 1997-1999
• Bioinformatics and Data Integration invited speaker, Washington, D.C. 1999.
• IBC-UK speaker for Structural Proteomics, 1999.
• TIGR Computational Genomics Meeting, 1998.
• IBC-USA speaker for Proteomics, 1998.
• IBC-UK speaker for Protein Informatics, 1998.
• Member of the science advisory committee for the Human Genome Project Program, produced by the Massachusetts Corporation for Education Telecommunication and funded by NIH, 1993-1997.
• Advisory member for the Exploratorium's Biological Initiative, 1997.
• Invited speaker and demonstrator at the 6th Annual Instructional Summer Institute at Utah State University, 1994.
• Member of the College Board Design Team for PaceSetter series, 1994.
• Invitational speaker at the 4th annual BioQuest Symposium, 1994.
• Invitational member of the College Board Design Team for "Predictability and Complex Systems" module development, 1994.
• Design team member for the Exploratorium's new Teaching Institute, 1993.

TEACHING EXPERIENCE

• 1985-1986 Pharmacology Committee Tutor, Case Western Reserve School of Medicine.
• Seminar Lecturer for “Introduction to Neural Networks”, Brandeis University, 1989
• NSF-sponsored seminars in Applications of Advanced Technologies

HONORS AND AWARDS

• ATP-NIST $1.8 million award for “Intelligent Informatics for Pathways”, 2000
• AAT/NSF 3-year awarded project: "Turning Information into Knowledge", 1995-1998.
• AAT/NSF 3-year awarded project: "Multi-level Science: from DNA to Populations", 1992-1995.
• Undergraduate research project stipendium for studying Murine Leukemia Viruses, Summer 1979, M.I.T.
• Undergraduate Thesis recognition award for work on: "Molecular Recombinants of Murine Leukemia Viruses Which Alter Tissue Specific Tropisms ", 1980-1981, M.I.T.

PROFESSIONAL SOCIETIES

• Science Commons MIT Fellow
• Organizer and Coordinator for W3C workshop on Semantic Web in Life Sciences
• W3C Member
• Founding member of BioPathways Consortium (http://www.biopathways.org).
• Editorial Board member for Drug Discovery Today, Elsevier-Reed.
• OMG Domain Contributing Member and LifeScience Research co-Chair
• ISCB member since 1994
• Pacific Symposium on Biocomputing session chair
• Founding member of Bio-Ontologies Consortium along with SmithKline-Beecham
• AAAS Member
• Genetic Society of America.
• International Neural Network Society.

BIBLIOGRAPHY

• Gudivada CR, Qu AX, Chen J, Jegga AG, Neumann EK, Aronow BJ, Identifying Disease-Causal Genes using Semantic Web-based Integration of Genomic-Phenomic Data. Journal of Biomedical Informatics Journal 2008.
• Feigenbaum L, Herman I, Hongsermeier T, Neumann E, Stephen S, The Semantic Web in Action, Scientific American December 2007, pp 64-71.
• Qu AX, Gudivada CR, Jegga AG, Neumann EK, Aronow BJ, Semantic Web-based Data Representation and Reasoning Applied to Disease Mechanism and Pharmacology, 2nd IEEE International Data mining and Bioinformatics 2007 513 (Accepted)
• Ranga Chandra Gudivada, Xiaoyan A. Qu , Anil G Jegga, Eric K. Neumann , Bruce J Aronow, "A Genome - Phenome Integrated Approach for Mining Disease-Causal Genes using Semantic Web", Workshop on Healthcare and Life Sciences, WWW2007, May 2007.
• Eric Neumann, Laurence Prusak, "Knowledge Networks in the Age of the Semantic Web", Briefings in Bioinformatics Briefings in Bioinformatics, 8(3):141-149, 2007.
• Bi-monthly column writer on “Science and the Web” for Bio-ITWorld (www.bio-itworld.com)
• Michael Schroeder, Eric Neumann: Editorial - Semantic Web for Life Sciences. J. Web Sem. 4(3): 167 (2006)
• Neumann, E, Finding the Critical Path: Applying the Semantic Web to Drug Discovery and Development. Drug Discovery World 6: 4 25-33, Fall 2005, JR Communications Publishers.
• Neumann, E, Quan D “BIODASH: A Semantic Web Dashboard for Drug Development?” Proceedings of Pacific Symposium on Biocomputing 2006, Stanford Press.
• Eric Neumann, Perspectives: “A Semantic Web for Life Sciences: Are we there yet?” Science -STKE, Issue: 283, p 23, 2005 .
• Davidov E, Clish CB, Oresic M, Meys M, Stochaj W, Snell P, Lavine G, Londo TR, Adourian A, Zhang X, Johnston M, Morel N, Marple EW, Plasterer TN, Neumann E, Verheij E, Vogels JT, Havekes LM, van der Greef J, Naylor S. Methods for the differential integrative omic analysis of plasma from a transgenic disease animal model.OMICS. 2004 Winter;8(4):267-88.
• Eric Neumann, Eric Miller, John Wilbanks, What the Semantic Web could do for the Life Sciences, Drug Discovery Today: BioSilico 2(6): 228-236 (2004).
• Oresic M, Clish CB, Davidov EJ, Verheij E, Vogels J, Havekes LM, Neumann E, Adourian A, Naylor S, van der Greef J, Plasterer T.Phenotype characterisation using integrated gene transcript, protein and metabolite profiling. Appl Bioinformatics. 2004;3(4):205-17.
• Clish CB, Davidov E, Oresic M, Plasterer TN, Lavine G, Londo T, Meys M, Snell P, Stochaj W, Adourian A, Zhang X, Morel N, Neumann E, Verheij E, Vogels JT, Havekes LM, Afeyan N, Regnier F, van der Greef J, Naylor S. Integrative biological analysis of the APOE*3-leiden transgenic mouse. OMICS. 2004 Spring;8(1):3-13.
• Eric Neumann and Jeffrey Thomas, Knowledge Assembly for the Life Sciences, Drug Discovery Today vol. 7, No. 20: S160 – S163 (2002).
• Eric Neumann and Vincent Schachter, The Informatics for Making Sense of the Genome: A Progress Report from the BioPathways Consortium, J. of Comparative and Functional Genomics, 2002 Vol 2: Issue 3: 115-118.
• Robin McEntire, Peter Karp, Neil Abernethy, David Benton, Gregg Helt, Matt DeJongh, Robert Kent, Anthony Kosky, Suzanna Lewis, Dan Hodnett, Eric Neumann, Frank Olken, Dhiraj Pathak, Luca Toldo, and Thodoros Topaloglou , (2000) “An Evaluation of Ontology Exchange Languages for Bioinformatics”, Proceeding of the 8th International Conference on Intelligent Systems for Molecular Biology, Eds. R. Altman, T. Bailey, P. Bourne, M. Gribskov, T. Lengauer, I.N. Shindyalov, L. Ten Eyck, and H. Weissig, AAAI Press, .
• Eric Neumann, Drug Discovery Industry is Moving to the CORBA Standard, in Biotechnology Software and Internet Journal, 16: 5,7 (1999).
• Eric Neumann, Wallace Feurzeig. Object-Object Transformation Language in Science and Mathematics, in Modeling and Simulation in Precollege Science and Mathematics Education, W. Feurzeig and N. Roberts, eds , Springer-Verlag.
• Eric Neumann, Wallace Feurzeig, Peter Garik, Allan Collins (USA) Object-Object Transformation Language and its Application to Games for Learning Computational Science Modelling, EuroLogo, 1997.
• Smith, L.A., X. Wang, A.A. Peixoto, E.K. Neumann, L.M. Hall, and J.C. Hall. 1996. A Drosophila calcium channel a1 subunit gene maps to a locus associated with behavioral and visual defects. J. Neurosci. 15: 7868-7879.
• Paul Horwitz, Eric Neumann, Joyce Schwartz: Teaching Science at Multiple Space Time Scales. CACM 39(8): 100-102 (1996).
• Horwitz, P. Neumann, E 1996. Turning information into knowledge: Hypermodels for science education. In project abstracts of the Applications of Advanced Technology Program Principal Investigator Meeting, Washington, DC, June.
• Eric Neumann, Hypermodeling: Connecting Media to Exploration (1996). Proceedings from ACM 96.
• Eric K. Neumann, David A. Wheeler, Adam Bernstein, Jamie W. Burnside and Jeffrey C. Hall (1992). Artificial Neural Network Classification of Drosophila Courtship Song Mutants. Biological Cybernetics, 66: 485-496.
• Adam Bernstein, Eric K. Neumann and Jeffrey Hall (1992). Temporal Analysis of Drosophila Courtship Song. J. Insect Behavioral, 5: 15-36.
• Eric K. Neumann, David Wheeler, Adam Bernstein, and Jeffrey Hall (1989). A Novel Method for the Learning, Detection and Analysis of Genotypic Discriminants from Behavioral Data International Joint Conference on Neural Networks (Washington, D.C., January 1990).
• E. K. Neumann (1988). neural disrupted: A gene required for embryonic neural development in Drosophila: Ph.D. Thesis, Case Western Reserve University.
• P. Mahowald, A. Furst, L. Perkins, E. Neumann, R. Huff and N. Perrimon, (1986). Cellular, Genetic and Molecular Analyses of Embryonic Neurogenesis, Department of Developmental Genetics and Anatomy, Case Western Reserve University, Cleveland, OH. Molecular Neurobiology of Drosophila , Cold Spring Harbor Laboratory.
• E. K. Neumann , A. Furst, L. A. Perkins, A.P. Mahowald. Identification of Genes Expressed in Differentiated Neural Cultures of Drosophila melanogaster (1986), Society for Neuroscience Abstracts Vol 12, 16th Annual Meeting, Washington, D.C.
• E. K. Neumann , and A.P. Mahowald (1987), Isolation and Characterization of a gene required for embryonic neural development in Drosophila, Society for Neuroscience Abstracts Vol 13, 17th Annual Meeting, Washington, D.C.